Relmada Therapeutics, Inc (NASDAQ:RLMD) Receives $10 80 Consensus PT from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Relmada Therapeutics, Inc. (NASDAQ:RLMD – Get Free Report) was the recipient of a significant decline in short interest in August. As of August 15th, there was short interest totalling 689,800 shares, a decline of 18.8% from the July 31st total of 849,900 shares. Based on an average daily trading volume, of 169,700 shares, the short-interest […]
Shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD – Get Free Report) have been assigned a consensus recommendation of “Hold” from the six analysts that are presently covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month […]
Relmada Therapeutics (RLMD) Set to Announce Quarterly Earnings on Tuesday themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Relmada Therapeutics (NASDAQ:RLMD – Get Free Report) and Timber Pharmaceuticals (NYSE:TMBR – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends. Insider & Institutional Ownership 59.1% of Relmada […]